Skip to main navigation
Skip to search
Skip to main content
Sort by:
Keyphrases
Nanoparticles
100%
Rheumatoid Arthritis
100%
Triptolide
100%
Intra-articular
100%
Multitherapy
100%
Hyaluronic Acid Hydrogel
100%
Near-infrared
42%
Irradiation
28%
Highly Effective
14%
Inflammation
14%
Drug Release
14%
In Vivo Imaging
14%
Phosphorylation
14%
Au Nanoparticles (AuNPs)
14%
Photothermal
14%
Clinical Application
14%
In Vitro Experiment
14%
Chronic Inflammatory Diseases
14%
Hyaluronic Acid
14%
Ultra-low Dose
14%
Collagen-induced Arthritis
14%
Cartilage
14%
Mammalian Target of Rapamycin (mTOR)
14%
Anti-inflammatory Properties
14%
P70S6K
14%
Transport Properties
14%
Antirheumatic Drugs
14%
Invasive Ability
14%
Gold Nanoparticles(AuNPs)
14%
Synoviocytes
14%
Fibroblast-like
14%
Drug Transport
14%
MTOR Pathway
14%
Migratory Capacity
14%
Synovial Inflammation
14%
Inflamed Joint
14%
Cross-linked Hyaluronic Acid
14%
Disease-modifying Antirheumatic Drugs (DMARDs)
14%
Release Properties
14%
Locally Produced
14%
Hydrogel System
14%
Multiple Joints
14%
Tyramine
14%
Artificial Tissue
14%
Hyaluronic Acid Conjugate
14%
Intra-articular Administration
14%
Tissue Model
14%
Medicine and Dentistry
Nanoparticle
100%
Inflammatory Arthritis
100%
Triptolide
100%
Rheumatoid Arthritis
100%
Restylane
100%
In Vitro
28%
Mammalian Target of Rapamycin
28%
Fibroblast
14%
Collagen-Induced Arthritis
14%
Inflammatory Disorder
14%
Low Drug Dose
14%
Anti-Inflammatory Drug
14%
Joint Injection
14%
Synovial Cell
14%
Drug Transport
14%
Gold Nanoparticle
14%
Synovitis
14%
Disease Modifying Antirheumatic Drug
14%
Tyramine
14%
Pharmacology, Toxicology and Pharmaceutical Science
Nanoparticle
100%
Rheumatoid Arthritis
100%
Inflammatory Arthritis
100%
Hyaluronic Acid
100%
Triptolide
100%
Inflammation
14%
Inflammatory Disease
14%
Chemotherapy
14%
Anti-Inflammatory Drug
14%
Collagen-Induced Arthritis
14%
Gold Nanoparticle
14%
Drug Release
14%
Drug Transport
14%
Synovitis
14%
Disease Modifying Antirheumatic Drug
14%
Tyramine
14%